Phosphorylated CREB is known to downregulate the pathological biomarkers of AD, including Aβ deposition and tau aggregation, and upregulates the expression of brain-derived neurotrophic factor (BDNF), the key neurotrophic factor that plays a vital role in neuronal survival and growth. This evidence concerns the gene MAPT and Alzheimer disease.